Minivelle Approved for Postmenopausal Osteoporosis Prevention
The FDA has approved a new indication with a new dose of Minivelle (estradiol transdermal system) for prevention of postmenopausal osteoporosis.
Hormone Replacement Therapy
Oral Testosterone Treatment Effective in Hypogonadal Men
Lipocine announced top-line results from its Phase 3 SOAR clinical trial evaluating the efficacy and safety of LPCN 1021, an oral testosterone agent in hypogonadal men with low testosterone.
Estrogen-Progestin Use Varied Over 40 Years
The use of estrogen-progestin has varied over the past 40 years, peaking in the 1990s and declining in the early 2000s.
- Loading...
Loading...
Loading... 
Loading...